News Overview

The company’s standalone net interest income logged growth of 21% yoy in Q4FY22 at Rs12,605 crore as against Rs10,431 crore in Q4FY21.

Australian share market closed on Monday, 25 April 2022, for Anzac Day holiday. Asian stocks tumbled on Monday amid lingering concerns about rapid US Federal Reserve rate rises and slowing growth as Covid cases continued to spread in China and authorities extended strict anti-pandemic lockdowns to Beijing. Powered by Capital Market – Live News

The crop with complete traceability would help the company to command a premium in both global and domestic markets.

Welspun Corp has received a major export order from South East Asia of approximately 55,000 MT, for manufacture and supply of pipes for a critical offshore application. This order would be executed from the companys facilities in India and majority of it would be supplied in this Financial Year. Powered by Capital Market – Live News

Zydus Lifesciences announced the publication of two manuscripts detailing the DREAM-ND and DREAM-D Phase 3 study results of Desidustat, a novel HIF-PH inhibitor in the prestigious American Journal of Nephrology. Desidustats development is based on the Nobel Prize in Medicine winning science on discoveries of the oxygen sensing mechanism of cells through hypoxia-inducible factor (HIF). Desidustat works by stabilizing the HIF complex and stimulating endogenous […]

ICICI Bank advanced 1.14% to Rs 755.85 after the bank delivered strong financial performance for the quarter and the year ended on 31 March 2022.

Record date for dividend is 29 April 2022

Indias total active caseload currently stands at 16,522. 2,541 new cases were recorded in last 24 hours. There were 1,862 recoveries in the last 24 hours. The recovery rate currently stands at 98.75%. Daily positivity rate is at 0.84%. Under the Nationwide Vaccination Drive,187.71 cr vaccine doses have been administered so far. Powered by Capital Market – Live News

Steel Authority of India Ltd has lost 4.9% over last one month compared to 4.97% fall in S&P BSE Metal index and 1.13% drop in the SENSEX

The drug maker has launched a novel fixed-dose combination (FDC) of a widely used DPP4 inhibitor (Dipeptidyl Peptidase 4 inhibitor), Teneligliptin, with Pioglitazone for type 2 diabetes in India.